NHS computer supplier faces dismissal for missing deadline
By New Statesman - 01 April 13:10

Computer Sciences Corporation has missed a critical deadline to install IT systems.

Genentech and Biogen Idec file complaint against GSK
By New Statesman - 29 March 12:12

Pharmaceutical company Genmab has reported that the biotechnology firms have filed a declaratory rel

Ford Motor rolls out PC power management
By New Statesman - 24 March 10:39

The program's power settings on Windows laptops and desktop computers are centrally controlled to re

Bayer Schering Pharma to step up investment in Asia
By New Statesman - 16 March 10:30

The German company is poised to expand its sales presence in India and Vietnam, reported the Wall St

Majority of patients' groups lack trust in pharma firms: PatientView
By New Statesman - 15 March 10:31

Pharmaceutical companies were considered untrustworthy by majority of patients’ organisations, accor

3M, Patient Care Technology Systems join hands on automated hand hygiene solution
By New Statesman - 01 March 12:04

3M and Patient Care Technology Systems (PCTS), a subsidiary of Consulier Engineering have signed an

Celgene opens European R&D hub for translational science
By New Statesman - 01 March 12:02

Celgene has launched Celgene Institute of Translational Research Europe (CITRE), a European hub for

Thermo Fisher Scientific acquires Ahura Scientific
By New Statesman - 01 March 12:01

Thermo Fisher Scientific has completed its previously announced acquisition of Ahura Scientific, a c

FDA grants marketing approval for Shire's Vpriv
By New Statesman - 01 March 11:25

FDA has granted marketing approval for Shire's Vpriv, a human cell line derived enzyme replacement t

Cannabis Science moves ahead with FDA clinical trial process
By New Statesman - 26 February 10:23

Cannabis Science has announced that the choice of initial cannabis-based pharmaceutical for FDA clin

Celgene opens European R&D hub for translational science
By New Statesman - 26 February 10:21

Celgene has launched Celgene Institute of Translational Research Europe (CITRE), a European hub for

AstraZeneca agrees to pay £505m to settle tax dispute
By New Statesman - 25 February 12:04

Anglo-Swedish drugs group AstraZeneca has agreed to pay £505m in back taxes to HM Revenue & Customs

QR Pharma receives US patent to treat Down Syndrome
By New Statesman - 25 February 10:35

QR Pharma, a developer of novel drugs to treat Alzheimer’s disease (AD), was issued the US Patent No

Helvoet Pharma to build new production facility in India
By New Statesman - 25 February 10:33

To further capitalise on its worldwide leadership in pharmaceutical rubber formulations, Helvoet Pha

Lundbeck expands Azilect marketing agreement with Teva in Asia
By New Statesman - 25 February 10:29

Lundbeck had expanded its agreement with Teva for Azilect to cover China, South Korea, Hong Kong, Ma

OFT says Reckitt rigged Gaviscon market
By New Statesman - 24 February 13:13

The Office of Fair Trading (OFT) has accused household and healthcare products maker Reckitt Benckis

Avinger merges with Sawtooth Labs
By New Statesman - 23 February 11:20

Avinger and Sawtooth Labs have merged to form a single organization under the Avinger name to develo

HeartWare concludes patient enrollment in advance clinical trial
By New Statesman - 23 February 11:18

HeartWare International, a provider of less invasive, miniaturized circulatory support technologies

Gilead wins FDA marketing approval for Cayston
By New Statesman - 23 February 11:17

Gilead Sciences (Gilead) has received marketing approval from US FDA for its Cayston (aztreonam for

Genentech's Avastin trial fails to meet primary endpoint
By New Statesman - 23 February 11:15

Genentech, a wholly owned member of the Roche Group, has announced that a Phase III study (AVAGAST)

ART enters into multi-year software license agreement with Nihon
By New Statesman - 23 February 11:11

Arrhythmia Research Technology (ART) has entered into a multi-year software license agreement with N

GSK warns consumers against denture adhesive risks
By New Statesman - 22 February 11:21

GlaxoSmithKline (GSK) Consumer Healthcare has issued a consumer advisory warning about the potential

Cappella presents Sideguard 3.25 at Joint Interventional Meeting in Rome
By New Statesman - 22 February 11:19

Cappella, a developer of dynamic solutions for the treatment of coronary bifurcation diseases, has p

Ablynx receives grant to accelerate ALX-0061 programme
By New Statesman - 22 February 11:16

Ablynx has received a grant worth €1.2m from the Flemish agency for Innovation by Science and Techno

Siemens Healthcare installs Acuson S2000 at Spire Wellesley Hospital in Essex
By New Statesman - 19 February 11:06

Siemens Healthcare has delivered an Acuson S2000 diagnostic ultrasound system to the newly refurbish

Diagnostic Imaging International plans to acquire MRI clinic
By New Statesman - 19 February 11:02

Diagnostic Imaging International (DIIG) is in the process of exploring potential acquisitions for a

AMRI acquires Excelsyn
By New Statesman - 19 February 11:00

AMRI has acquired Excelsyn, a provider of development and large scale manufacturing services to larg

Taro to terminate manufacturing operations at Irish facility
By New Statesman - 19 February 10:57

Taro Pharmaceutical Industries (Taro) has decided to discontinue manufacturing operations at the ste

Bayer makes A1CNow SelfCheck system available in US pharmacies
By New Statesman - 18 February 11:11

Bayer has reported that A1CNow SelfCheck, an A1C system for at-home use, is available for in-store p

Sanofi-Aventis enters into research partnership with Aviesan in France
By New Statesman - 18 February 11:05

Sanofi-aventis has signed a research partnership with Aviesan (National Alliance for Life Sciences a

Pages